niacinamide has been researched along with dinoprostone in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Gross, GJ; Pieper, GM | 1 |
| Ban, M; Enomoto, I; Hashimoto, H; Ito, T; Ogawa, K; Sakai, K | 1 |
| Hata, S; Koide, T; Matsushita, H; Mizukami, M; Nakano, M; Neichi, T; Noda, Y; Yamazaki, T | 1 |
| Monteiro-Riviere, NA; Riviere, JE; Zhang, Z | 1 |
| Blaha, M; Bowers, W; DuBose, D; Kohl, J; Walker, J | 1 |
| Alarcón de la Lastra, C; Martín, A; Sánchez-Fidalgo, S; Sánchez-Hidalgo, M; Villegas, I | 1 |
| Chuang, LM; Guo, RT; Hu, SM; Ko, TP; Wang, AH; Wu, YH | 1 |
| Edwards, JP; Emens, LA | 1 |
| Katano, M; Kiyota, A; Koya, N; Morisaki, T; Onishi, H; Tanaka, H; Umebayashi, M | 1 |
| Berg, AH; Bhasin, MK; Clish, CB; Karumanchi, SA; Khankin, EV; Kim, W; Parikh, SM; Rhee, EP; Stillman, IE; Tran, MT; Zsengeller, ZK | 1 |
11 other study(ies) available for niacinamide and dinoprostone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effect of cyclooxygenase blockade on the beneficial actions of nicorandil in the stunned myocardium of dogs.
Topics: Animals; Blood Pressure; Cardiomyopathies; Coronary Circulation; Cyclooxygenase Inhibitors; Dinoprostone; Dogs; Female; Heart Rate; Hemodynamics; In Vitro Techniques; Indomethacin; Male; Myocardial Reperfusion Injury; Niacinamide; Nicorandil; Prostaglandins; Thromboxane A2; Time Factors; Vasodilator Agents | 1989 |
SG-75 induction of increased coronary outflow and PGE1 from ischemic areas in dogs with experimental myocardial infarction.
Topics: Alprostadil; Animals; Coronary Circulation; Dinoprostone; Dogs; Indomethacin; Lactates; Myocardial Infarction; Myocardium; Niacinamide; Nicorandil; Prostaglandins E; Vasodilator Agents | 1982 |
Effects of AVS (1,2-bis(nicotinamido)propane) on platelet function and vascular endothelium.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Blood Vessels; Cerebrovascular Disorders; Collagen; Dinoprostone; Endothelium; In Vitro Techniques; Mice; Microscopy, Electron, Scanning; Niacinamide; Platelet Aggregation; Prostaglandins E; Rabbits; Rats; Rats, Inbred Strains; Thromboembolism; Thrombosis; Thromboxane A2 | 1984 |
Evaluation of protective effects of sodium thiosulfate, cysteine, niacinamide and indomethacin on sulfur mustard-treated isolated perfused porcine skin.
Topics: Animals; Cysteine; Dinoprostone; Female; Indomethacin; Mustard Gas; Niacinamide; Skin; Skin Diseases; Swine; Thiosulfates | 1995 |
Il-1-related cytokine responses of nonimmune skin cells subjected to CEES exposure with and without potential vesicant antagonists.
Topics: Benzimidazoles; Biomarkers; Calmodulin; Cells, Cultured; Cysteine Proteinase Inhibitors; Dinoprostone; Drug Synergism; Enzyme Inhibitors; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Irritants; Keratinocytes; Leupeptins; Mustard Gas; Niacinamide; Poly(ADP-ribose) Polymerase Inhibitors; Receptors, Interleukin-1; Receptors, Interleukin-1 Type II; Sialoglycoproteins | 2000 |
PARP inhibition reduces acute colonic inflammation in rats.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Colitis; Colon; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gastrointestinal Agents; Isoquinolines; Membrane Proteins; Niacinamide; Peroxidase; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar; Time Factors; Trinitrobenzenesulfonic Acid | 2007 |
Structural basis for catalytic and inhibitory mechanisms of human prostaglandin reductase PTGR2.
Topics: 15-Oxoprostaglandin 13-Reductase; Alcohol Dehydrogenase; Amino Acid Sequence; Animals; Catalysis; Dinoprostone; Guinea Pigs; Humans; Indomethacin; Kinetics; Mice; Models, Molecular; Molecular Conformation; Molecular Sequence Data; Niacinamide; Protein Binding; Sequence Alignment; Sequence Homology, Amino Acid | 2008 |
The multikinase inhibitor sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE₂ in murine macrophages.
Topics: Animals; Benzenesulfonates; Cell Line; Dinoprostone; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Interleukin-10; Interleukin-12; Macrophages; Mice; Niacinamide; p38 Mitogen-Activated Protein Kinases; Phenylurea Compounds; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; Sorafenib; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Toll-Like Receptors | 2010 |
Combining celecoxib with sorafenib synergistically inhibits hepatocellular carcinoma cells in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Celecoxib; Cell Proliferation; Dinoprostone; Drug Synergism; Fluorescent Antibody Technique; Humans; In Vitro Techniques; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrazoles; Sorafenib; Sulfonamides; Tumor Cells, Cultured | 2013 |
PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection.
Topics: 3-Hydroxybutyric Acid; Acute Kidney Injury; Adipose Tissue; Amino Acids; Animals; Cytokines; Dinoprostone; Humans; Ischemia; Kidney; Male; Mice; Mice, Inbred C57BL; Mitochondria; NAD; Niacinamide; Nicotinamide Phosphoribosyltransferase; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Signal Transduction; Stress, Physiological; Transcription Factors | 2016 |